ALLEGAN, Mich., April 12, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg (a

SKILLMAN, N.J., Feb.

ALLEGAN, Mich., Jan.

ALLEGAN, Mich., Nov. 28, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it received final approval from the U.S.

PARSIPPANY, N.J., July 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc.